DOI: 10.36347/sjams.2021.v09i02.013

Pages: 241-247

Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age. Anti-Mullerian hormone (AMH) has a glycoprotein dimer structure and is a member of the transforming growth factor-β (TGF-β) family. AMH is produced by the granulosa cells surrounding preantral and antral follicles and has an important role in the development and maturation of follicles. Several studies have suggested that AMH serum levels may be a marker for polycystic ovary syndrome (PCOS). Serum AMH has also demonstrated its utility in the treatment of infertility. Objective: To assess relationship of AMH level with ovarian response in Polycystic Ovary Syndrome (PCOS) patients. Methods: This is a cross sectional comparative study which was held at Sylhet women’s Medical college from 2018 to 2019. Result: In this study 45 respondent had participated. For statistical analysis of this study AMH divided by two sub groups Group A (<8) and Group B (8<) and study found that 50.7% respondent had AMH which is Group A (<8). This study also revealed the negative correlation between AMH and follicle size (r= -0.288). On other hand AMH Group have positive correlation between LH (r = 0.238. Besides follicle size have positive correlation with ET (r=0.044) which is statistically significant. Conclusion: From this study it is easily understandable that AMH plays an important role to predict ovarian response to ovulation education in Polycystic Ovary Syndrome (PCOS) patients.